Redacted J&A or a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment, consumables, controls, and any necessary services to conduct Flow Cytometry Requirement
SOL #: 23-P-0054Justification
Overview
Buyer
DEPT OF DEFENSE
Dept Of The Army
W40M MRC0 WEST
JBSA FT SAM HOUSTON, TX, 78234-4504, United States
Place of Performance
DWG, TX
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
PSC
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Jan 21, 2026
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
This requirement was for a FDA Approved Flow Cytometry Instrumentation must be able to have fully automated discrete random-access capabilities; be able to store reagents at the Food and Drug Administration (FDA) storage levels; be capable of barcode identification; be able to print patient results as one per page; have the ability to interface with the Military Health System (MHS) Genesis and the Risk Management Framework (RMF) and Health Insurance Portability and Accountability Act (HIPAA) compliant.
People
Points of Contact
Medina L. WoodsonPRIMARY
Salameya PaulouskayaSECONDARY
Files
Files
Versions
Version 1Viewing
Justification
Posted: Jan 21, 2026